Position in AMGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$335,685
+$98,187 QoQ
Shares Held
927
+37.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,474
of 3,140 holders
Holding Since
Jun 2020
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RMR Wealth Builders holds $24,634,504 across 7 Drug Manufacturers - General names. AMGN ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,409 | $8,886,577 | |
| 2 | JNJ |
Johnson & Johnson
|
22,056 | $5,601,562 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
39,220 | $4,955,054 | |
| 4 | MRK |
Merck & Co., Inc.
|
18,454 | $2,371,339 | |
| 5 | ABBV |
AbbVie Inc.
|
7,287 | $1,833,700 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
11,291 | $650,587 | |
| 7 | AMGN |
Amgen Inc
This page
|
927 | $335,685 |
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $335,685 | 927 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $237,498 | 675 | Shares | Sole | 2026-04-22 | |
| 2021-03-31 | $58,221 | 234 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $7,587 | 33 | Shares | Sole | 2021-02-26 | |
| 2020-06-30 | $7,547 | 32 | Shares | Sole | 2020-08-19 | |
| No filing history on record for this holder in this stock. | ||||||